Page last updated: 2024-08-17

quinidine and tyrosine

quinidine has been researched along with tyrosine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellman, K; Knegtel, RM; Settimo, L1
Bett, GC; Morales, MJ; Qu, YJ; Rasmusson, RL; Strauss, HC; Wang, S1
Ferrer, T; Navarro-Polanco, RA; Sănchez-Chapula, JA; Sanguinetti, MC1
Jebe, E; Petrunkina, AM; Töpfer-Petersen, E1
Bianchi, E; Cadet, P; Esch, T; Goumon, Y; Mantione, KJ; Shen, L; Sonetti, D; Stefano, GB; Zhu, W1
Dalvi, P; Gokulgandhi, M; Kesh, S; Kohli, T; Mitra, AK; Pal, D; Patel, M1
Holst, J1
Mitra, A1

Other Studies

8 other study(ies) available for quinidine and tyrosine

ArticleYear
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect.
    The Journal of physiology, 2003, Jan-15, Volume: 546, Issue:Pt 2

    Topics: Allosteric Regulation; Amino Acid Sequence; Amino Acid Substitution; Animals; Dose-Response Relationship, Drug; Female; Kv1.4 Potassium Channel; Lysine; Molecular Sequence Data; Mutation; Oocytes; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Time Factors; Tyrosine; Xenopus laevis

2003
Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.
    Molecular pharmacology, 2003, Volume: 63, Issue:5

    Topics: Binding Sites; Cation Transport Proteins; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Membrane Proteins; Phosphodiesterase Inhibitors; Point Mutation; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Structure, Tertiary; Pyrazines; Quinidine; Quinine; Quinolines; Trans-Activators; Transcriptional Regulator ERG; Tyrosine

2003
Regulatory and necrotic volume increase in boar spermatozoa.
    Journal of cellular physiology, 2005, Volume: 204, Issue:2

    Topics: Animals; Annexin A5; Cell Size; Chloride Channels; Enzyme Inhibitors; Hypertonic Solutions; Male; Necrosis; Phenols; Phosphoprotein Phosphatases; Phosphorylation; Protein-Tyrosine Kinases; Quinidine; Semen Preservation; Spermatozoa; Staining and Labeling; Staurosporine; Swine; Tamoxifen; Tyrosine; Vanadates

2005
Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling.
    Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:11

    Topics: alpha-Methyltyrosine; Animals; Base Sequence; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; DNA, Complementary; Dopamine; Enzyme Inhibitors; Ganglia, Invertebrate; Molecular Sequence Data; Morphine; Mytilus edulis; Quinidine; RNA, Messenger; Tyramine; Tyrosine; Tyrosine 3-Monooxygenase; Up-Regulation

2005
Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells.
    International journal of pharmaceutics, 2013, Feb-25, Volume: 443, Issue:1-2

    Topics: Biological Transport; Cell Culture Techniques; Cell Line, Tumor; Chromatography, Liquid; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity; Tandem Mass Spectrometry; Temperature; Time Factors; Tyrosine

2013
Letter to the editor.
    International journal of pharmaceutics, 2013, Oct-15, Volume: 455, Issue:1-2

    Topics: Humans; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Tyrosine

2013
Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells [Int. J. Pharm. 443 (2013) 245-253].
    International journal of pharmaceutics, 2013, Oct-15, Volume: 455, Issue:1-2

    Topics: Humans; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Tyrosine

2013